News Center

Home page

Peak Report

News reports

The group company held the 2018 annual board of directors and the board of supervisors to review and approve the annual work report and other related proposals

Release time:

2020-07-22

Group Company Convenes 2018 Board of Directors and Board of Supervisors

to Review and Approve Annual Work Report and Other Related Proposals

News 4 26 , Chairman of the Group Company Jiang Xiaomeng presided over the 10 Meeting of the 10th Board of Directors of the Company, deliberated and approved 22 related reports and proposals such as 2018 annual board of directors report and 2018 annual general manager business report.

General Manager's report pointed out that 2018 is the 31st anniversary of Peak Start-up 60#. According to the five-year development plan and annual business plan, the company has carried out various operation and management work in an orderly manner around the general policy of "determination to reform, deepen management, and promote all-round high-quality development of the enterprise " , the business plan formulated by the board of directors at the beginning of the year was well completed. The company realized operating income of 33.62 .7 billion yuan for the whole year, up 18.95% year on year, net profit attributable to shareholders 58,850.21 yuan, earnings per share reached 1.71 yuan, up 68.87% year on year, reaching a new record high. At the end of the year, total assets 49.01 .7 billion yuan, up 17.38% year on year; net assets attributable to shareholders were 31.63 .1 billion yuan, up 20.38% year on year.

With the deepening of the country's supply-side structural reform, the effect of cement de-capacity has been highlighted, 2018 The supply and demand relationship in most parts of the country has been better improved, and the overall profitability of the industry has been greatly improved. The company's cement subsidiaries adhere to the "cost leadership " strategy, through continuous optimization of organizational structure, strengthen technological transformation, effectively control production costs, improve labor productivity. Daye Jianfeng has continuously strengthened the construction of quality management system, strengthened the advanced nature of process technology, and completed a number of technical improvement projects, such as kiln tail preheater technical transformation, raw material mill technical transformation, kiln tail desulfurization technical transformation, and achieved good results. After scientific arrangement and implementation of the plan, sales volume and price have been improved. Yunnan Jianfeng firmly grasped the key projects and Jinghong market, and won the optimization of key projects with high-quality service and good reputation. While the sales volume increased, it ensured that the price continued to run at a high level. At the end of 2018 , the company made a decision to acquire all the shares of Guizhou huangpinggu longmingchuan cement co., ltd. and will continue to promote the construction of its off-site technological transformation project (with waste heat power generation) of its new dry cement production line with a daily output of 4500 tons of clinker, further expanding the company's main business scale and enhancing its core competitiveness. In

2018 , the growth rate of the pharmaceutical industry slowed down due to policies such as medical insurance fee control, bidding and price reduction, and 4+7 urban drug procurement. However, with the improvement of the aging degree of society and the enhancement of people's awareness of health care, the pharmaceutical market demand is strong. 2018 , Jianfeng Pharmaceutical carried out extensive investigation and project negotiation around the company's strategic planning, and achieved certain results. Jianfeng Pharmaceutical completed the holding and capital increase of Shanghai North Card, and acquired Anhui Zhongwang through Shanghai North Card, laying the foundation for Jianfeng Pharmaceutical to build a bulk drug manufacturing base and further improving the company's pharmaceutical business industry chain; the annual output of 20 .8 billion solid preparation project (international project) in Jinxi production base of Jianfeng pharmaceutical industry has been officially launched, and the planning and design, equipment selection, product screening and other work are progressing in an orderly manner. The establishment of Anhui Jianfeng Beika Pharmaceutical Small Molecule Targeted Drug Research Institute will further improve the company's research level of antineoplastic drugs. During the reporting period, the company increased its investment in drug research and development, and the clinical trials of Jianfeng Pharmaceutical's new anti-tumor drug DPT progressed steadily. The preclinical research of Jianfeng Yien antitumor drug JFAN-1001 is progressing smoothly. At present, preclinical toxicological, pharmacodynamic and pharmacokinetic studies have been fully carried out, and patent applications in the United States, Canada, Japan, Europe, Australia and China have been successfully completed. Jianfeng Pharmaceutical also has a number of new drugs in various stages of research and development. It has completed the pharmaceutical research of imatinib mesylate tablets and obtained BE filing. Completed the pharmaceutical research of desvenlafaxine succinate sustained-release tablets and passed the ethical review. New progress has been made in the work of "consistency evaluation " . The process, quality research and bioequivalence test of paroxetine hydrochloride tablets have been completed and reported to the National Drug Examination Center. In addition, in the face of "two-vote system " , "4+7 city drug volume procurement " and other policies brought about by market changes, the company actively formulate differentiated sales policies, integrate regional resources, and make useful attempts for marketing transformation.

2018 , the company's other business sectors also better achieved their business objectives, peak health continued to promote the common development of terminals and e-commerce, through the network platform, exhibitions, media and other ways to carry out investment, according to market changes to improve the marketing model. Jianfeng International Trade has completed the construction of the new warehouse (e-commerce logistics park) project, and introduced Aneng Logistics and Zhongtong Express into the park for operation. Peak Cable actively develop new customers, expand the OEM business, operating income has achieved a greater growth. On the day of

, the company also held the 107 meeting of 6 of the 9th board of supervisors, deliberated and approved the company's 2018 annual board of supervisors work report, 2018 annual financial final accounts report and other 9 related reports and proposals. (Yu Fruit)

More information

The company fully deploys 2018 work

On January 27, the group company held a business analysis meeting to review and summarize the work in 2017, arrange and deploy the work for the new year, and put forward work requirements. At the meeting, various professional companies and directly affiliated enterprises reported on the overall work situation in 2017, focusing on analyzing the existing problems and deficiencies, and proposing corresponding solutions and work plans for 2018. Xiang Chongping, deputy general manager of the group company, systematically combed the current human resources efficiency and human resources development of the company. Chen Tianci, chairman of the board of supervisors, made a report and analysis on the "three reductions and three improvements" and the safety and environmental protection work in 2017. Lan Xiaolong, head of finance, analyzed the risks and challenges currently faced by the company according to the operating data and financial situation of its subordinate enterprises. The functional departments and offices of the headquarters also made a brief report on their annual work. Yu Jianhong, general manager of the group company, made a comprehensive review of the company's operation in 2017, compared and analyzed the main economic indicators of various industrial sectors, and pointed out that looking for new investment and development projects around strategic objectives, promoting the optimization of organizational structure and post setting, significantly improving the level of information management, improving the ability of fund management and tax planning, achieving certain results in scientific and technological innovation and technological transformation, and strengthening marketing management and market expansion, safety and environmental protection work is basically up to standard, training and talent development have achieved new results and other work highlights; at the same time, it summarizes and reflects on the shortcomings in strategic decision-making, management innovation, performance appraisal, market operation, and talent team building. After analyzing the current macroeconomic situation and the future trends of various related industries, Yu Jianhong informed

2020

07-31

Peak Pharmaceutical Invests in Shanghai North Carolina to Build API R & D and Production Base

News from our newspaper On January 19, the group company held the second meeting of the tenth board of directors and reviewed and approved the "Proposal on Foreign Investment of Subsidiary Jianfeng Pharmaceutical." On the same day, Jianfeng Pharmaceutical signed an agreement to invest in Shanghai North Carolina Pharmaceutical Technology Co., Ltd. (hereinafter referred to as "Shanghai North Carolina") by acquiring shares and increasing capital. Shanghai Beika is a high-tech enterprise in Shanghai. It has an academician expert workstation and a number of Shanghai high-tech achievements transformation projects. It has won the title of "second prize for scientific and technological progress" in Songjiang District, Shanghai, "patent pilot enterprise" and "enterprise technology center" in Songjiang District, Shanghai. The company has strong research and development capabilities and has obtained 14 patents. At present, its main business is to provide products and customized services for domestic and foreign pharmaceutical companies. The products mainly include Tinib, alkaloids, carbohydrates and other anti-tumor drug intermediates. The customized services are mainly CDMO (contract development and manufacturing) of new drugs and intermediates. Shanghai North Carolina has two wholly-owned subsidiaries, Anhui Changtai Chemical Co., Ltd. (hereinafter referred to as "Changtai Chemical") and Anhui North Carolina Pharmaceutical Co., Ltd. (hereinafter referred to as "Anhui North Carolina"). Changtai Chemical is a pesticide manufacturer designated by the Ministry of Industry and Information Technology. It was established in July 2007. It now has three chemical synthesis workshops and a pesticide preparation compounding workshop, with 10 product approvals and 13 patents. Anhui North Carolina was established in December 2016. Its business scope includes the customization, production and sales of chemical raw materials and pharmaceutical intermediates, and the wholesale and retail of chemical raw materials and products (except hazardous chemicals

2020

07-30

Peak Pharmaceutical Invests in Shanghai North Carolina to Build API R & D and Production Base

2020

07-31

Jianfeng Pharmaceutical was rated as a provincial trademark brand demonstration enterprise

On December 28, 2017, Zhejiang Administration for Industry and Commerce announced the list of trademark brand demonstration counties (cities, districts), demonstration towns (streets) and demonstration enterprises in Zhejiang Province in 2017. Jianfeng Pharmaceutical Company was identified as a trademark brand demonstration enterprise, and it was also the only enterprise in Jinhua City to enter the list. Peak Pharmaceutical was established in 1998 and obtained the first registered trademark in 1999. Since then, Jianfeng Pharmaceutical has been actively carrying out brand building in accordance with the requirements of the Trademark Law and other laws and regulations, and has set up an intellectual property department to carry out trademark management, rights protection and other activities; it has established a sound trademark management system, strictly in accordance with the provisions of the Trademark Law to supervise and manage the use of trademarks inside and outside the enterprise, and safeguard the legitimate rights and interests of the enterprise. Establish strategic cooperation with professional institutions, for trademark applications, renewals and other work. In recent years, Jianfeng Pharmaceutical has also explored trademark investment, creating value through intangible assets such as trademarks and brands, promoting efficiency improvement, and further expanding corporate influence; at the same time, it has continuously increased investment in new product research and development and technological transformation, and actively Declare various patents to provide strong support for brand building with technological innovation. According to incomplete statistics, Jianfeng Pharmaceutical and its subsidiaries currently have more than 120 valid trademarks, including 1 well-known trademark in China, 2 well-known trademarks in Zhejiang Province, 5 well-known trademarks in Jinhua City, and 2 overseas registered trademarks; Obtained more than 40 domestic and international patents. Trademark is an important part of intellectual property rights, in the knowledge economy, brand effect is increasingly becoming the leading force of economic development.

2020

07-31

Peak Pharmaceutical Invests in Shanghai North Carolina to Build API R & D and Production Base

2020

07-31

The company was rated as an advanced unit of the city's focus on talent and love talent.

News from our newspaper On December 11, the Talent Work Leading Group of the Jinhua Municipal Committee of the Communist Party of China commended the advanced units of Jinhua City that value talents and love talents. 36 units including Jianfeng Group won this honor. The selection of advanced units that value talents and love talents is a measure taken by the Jinhua Municipal Party Committee to further create a good atmosphere of focusing on talents and loving talents, fully respect and make good use of the first resource of talents, serve innovation to drive development, and implement the development strategy of strengthening the province with talents and innovation. The enterprises and institutions that have won this honorary title have always regarded talents as the fundamental driving force for development for a long time, regarded the investment of talents as the most effective investment, and integrated the love of talents into the unit culture. Remarkable achievements have been made in gathering talents, achieving talents, transforming and upgrading, and accelerating development. The Jinhua Municipal Party Committee requires the majority of employers to learn from advanced units, vigorously promote the trend of focusing on talents and loving talents, remove the obstacles to the talent development system and mechanism, and in accordance with the requirements of "walking in the forefront and jointly building Jinhua", in order to promote the construction of a modern metropolitan area and accelerate the construction of the province An important growth pole for high-quality development provides talent support and intellectual guarantee. (this newspaper reporter)

2020

07-31

< 1...38 39 40...61 > 跳转到页